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Objective To investigate the natural susceptibility to 71antimicrobial agents of103 Listeria strains
belonging to all known Listeria species (L.monocytogenes (N 21), L. innocua (N 21), L. seeligeri (N 21), L.
ivanovii (N19), L.welshimeri (N11), and L. grayi (N10)).
Methods MICswere determined using amicrodilution procedure in H-Medium.
Results All listeriaewere naturally sensitive or intermediate to tetracyclines, aminoglycosides, penicillins
(except oxacillin), loracarbef, cefazoline, cefaclor, cefotiam, cefoperazone, carbapenems, macrolides,
lincosamides, glycopeptides, dalfopristin/quinupristin, chloramphenicol and rifampicin (probably except L.
grayi). Listeria spp. were naturally resistant or intermediate tomost `modern'cephalosporins (cefetamet,
ce¢xime, ceftibuten, ceftazidime, cefdinir, cefpodoxime, cefotaxime, ceftriaxone, cefuroxime), aztreonam,
pipemidic acid, dalfopristin quinupristin and sulfamethoxazole. Signi¢cant di¡erences in natural
susceptibility among the species were seenwith the quinolones, trimethoprim, co-trimoxazole, rifampicin,
fosfomycin and fusidic acid. It seems likely that L. grayi is naturally resistant to all antifolates; the species was
least susceptible to rifampicin andmost susceptible to quinolones, whereas L. ivanoviiwas naturally resistant
tomost quinolones. L. ivanoviiwas naturally sensitive to fosfomycin, whereas L. innocua and L.monocytogenes
were naturally resistant. L. ivanoviiwas also themost susceptible species to fusidic acid.
Conclusions The present studydescribes a database on the natural susceptibility of Listeria spp. to awide
range of antibiotics, which can be used tovalidate susceptibility testing results of thesemicroorganisms.
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I N T R O D U C T I O N
Within the Clostridium^Lactobacillus^Bacillus branch of bac-
teria, the genus Listeria forms a relatively homogeneous taxon
of Gram-positive, motile, facultative anaerobic microorgan-
isms which is most closely related to the genus Brochothrix
[1,2]. Listeriae are widely distributed in nature, having been
isolated from the feces of humans and several animals, from
di¡erent soils, plants, and aquatic environments, and food of
animal and vegetable origin (cheese, milk, eggs, sausages,
vegetables) [1]. Six Listeria species are known to exist in two
closely related but distinct lines of descent [3,4]; one line
includes the important pathogens L. monocytogenes and L. iva-
novii, but also a`pathogenic' listeriae (L. innocua, L. seeligeri, and
L. welshimeri); the other line contains the strains of L. grayi.An
additional s`pecies',`L. murrayi', was shown to be closely related
to L. grayi and was reclassi¢ed into a subgroup of L. grayi in
1992 [5]; L. grayi is currently considered to contain two sub-
species called L. grayi subsp. grayi and L. grayi subsp.murrayi.
From a medical point of view, L. monocytogenes is the most
important Listeria species, causing a wide spectrum of clinical
syndromes in humans, summarized as listeriosis. Clinical fea-
tures range from mild in£uenza-like illness to meningitis,
frequently accompanied by septicemia, and meningoencepha-
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litis [1]. L. ivanovii mainly causes abortion in sheep, but cases
of listeriosis in cattle and humans have also been reported [6^
8]. Although human listeriosis due to listeriae not belonging
to L. monocytogenes and L. ivanovii seems to be exceptional,
these species possess the potential to cause human disease.
Strains of nearly all Listeria species are consumed through
food, drinks (including pasteurized milk) and water, often in
large amounts, and pathogenic properties have been found in
a`pathogenic' listeriae as well [9,10]. Treatment of infections
due to opportunistic bacteria may become a problem, because
many of these bacteria, although generally showing low viru-
lence, are naturally resistant to numerous antibiotics.
With the exception of L. monocytogenes, little information
is available on the antimicrobial susceptibilities of Listeria spp.,
including natural susceptibility patterns. The aim of the pre-
sent studywas to establish a database of the natural susceptibil-
ities of all known Listeria species to awide range of antibiotics.
In particular, it was investigated whether there are di¡erences
in natural susceptibilities between the species.
M A TE R IA L S A N D M E TH O D S
Bacterial strains
Twenty L. innocua, 20 L. seeligeri, 19 L. monocytogenes, 18 L. iva-
novii (subsp. ivanovii) and 10 L. welshimeri strains were kindly
provided by Merlin-Diagnostika (Bornheim, Germany) and
Gabi Eifert (Beerfelden, Germany). All these strains were
derived from the Special Listeria Culture Collection (SLCC)
of Heinz Seeliger, actually held by Herbert Hof, Mannheim,
Germany. The tested SLCC strains were predominantly iso-
lated in the USA and di¡erent European countries (Austria,
Belgium, Germany, France, Hungaria, Luxembourg, Norway,
Slovakia, Switzerland, UK) and were of clinical, mammalian
and environmental origin. L. innocua, L. seeligeri and L. welshi-
meri strains were mainly isolated from grass, cereals and forage
plants, but isolates from animals and human feces were
included. The tested SLCC strains of L. ivanoviiwere derived
from sheep, rodents, monkeys, human feces, cereals and
leaves. Most L. monocytogenes strains were of human origin and
comprised blood and cerebrospinal £uid specimens, but sheep
and avian isolates were also tested. L. monocytogenes SLCC
2482 (source not available), L. monocytogenesATCC15313 (iso-
lated from a rabbit), L. innocua ATCC 33090 (isolated from a
cow brain) and one food isolate of L. ivanovii subsp. ivanovii
and L. seeligeri were kindly provided by Johannes Kra« mer,
Bonn, Germany. Five L. grayi strains were kindly submitted by
Jacques Bille (Lausanne, Switzerland). Apart from one sheep
isolate, these strains originated from humans and were taken
from blood (N 2), cerebrospinal £uid and a swab from a
nose. L. grayi ATCC 19120 (isolated from chincilla feces) was
kindly provided by Jocelyn Rocourt (Institut Pasteur, Paris,
France). The type strain of `L. murrayi', L. grayi subsp. murrayi
ATCC 25401 (isolated from standing corn stalks and leaves in
the USA) and L. grayi CCUG 24933 (isolated from human
feces in Italy) were derived from the Swedish Culture Collec-
tion of the University of Go« teborg. Two additional L. grayi
strains of unknown origin and a food isolate of L. welshimeri
were kindly provided by Herbert Hof, Mannheim, Germany.
All strains from clinical specimens were initial isolates from
di¡erent patients.
Identi®cation
Identi¢cation was carried out as described previously [11].
The assignment of L. ivanovii strains to L. ivanovii subsp. ivano-
viiwas performed biochemically on the basis of acid produc-
tion from ribose and N-acetyl-b- D-mannosamine, as
described by Boerlin et al [12].
Antibiotic susceptibility testing
MICs were determined using a microdilution procedure in
H-Medium, consisting of agarose (4.5 g), Columbia broth
(210 g) (Difco Laboratories, Detroit, MI, USA), glucose (30
g), yeast extract (30 g) (Difco Laboratories), neopeptone (12 g)
(Difco Laboratories), aqua dest. (4830mL), hematin solution
(540mL, 0.3 g of hematin added to 600mL of 0.1M NaOH)
and Tween-80, 10% (90mL). Nine milliliters of pyridoxine^
NAD solution (0.2 g of pyridoxine 0.5 g of NAD 3000
mL of aqua dest.) and 1mL of an appropriate bacterial suspen-
sion in physiologic saline was added to 90mL of H-medium,
resulting in a mixture containing 3105 CFU/mL. Cultures
(18^24 h) of the bacteria grown on sheep blood agar at 36 C
under CO2 pressure (5%) were used for the preparation of the
inocula. Antibiotic-containing microtiter plates (Merlin-
Diagnostica, Bornheim, Germany) were inoculated with 100
mL of the mixture and incubated for 20 h at 36 C. MIC values
were read by a photometer (Labsystems Multiskan Multisoft,
Helsinki, Finland), and the data were evaluated using a table
calculation program. In addition toH-Medium, representative
strains of each species were also tested in cation-adjusted
Mueller^Hinton broth (CAMHB, Difco Laboratories). For
susceptibility testing using this medium, an incubation time
of 48^72 h (36 C)was required.
Evaluation of natural antibiotic susceptibility
Plotting the MIC of a particular antibiotic for one species
against the number of strains found with the respective MIC
usually results in a bimodal distribution. One peak with rela-
tively low MICs represents the natural population, and one
peak with higher MICs represents the strains with acquired
(secondary) resistance. Analysis of the MIC distribution of all
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strains of one species for each antibiotic permitted determina-
tion of the biological thresholds, which limit the natural
population at high MICs but not those strains with secondary
resistance.Whether the MIC values of the natural population
were above or below the breakpoints of the standards, which
assess the clinical susceptibility, was investigated. When the
natural population was sensitive or intermediate according to
the cited standard, it was described as naturally sensitive or
naturally intermediate, respectively.When the natural popula-
tion was clinically resistant, it was described as naturally
(intrinsically) resistant. (The method in detail has been
described previously [13^15].)
It should be noted that clinical breakpoints have not been
de¢ned by the most popular standards to include Listeria spe-
cies. Apart from aminopenicillins and penicillin G, for which
clinical breakpoints for Listeria susceptibility testing are
de¢ned according to the National Committee for Clinical
Laboratory Standards (NCCLS) [16], in the present study the
NCCLS criteria for staphylococci were applied [17]. For those
antibiotics for which neither Listeria nor Staphylococcus assess-
ment criteria were available, breakpoints for sensitivity were
de¢ned as follows: streptomycin, R8mg/L; neomycin, R8
mg/L; spectinomycin, R32mg/L; apramycin, R16mg/L;
ribostamycin,R16mg/L; lividomycin A,R16mg/L; pipera-
cillin, R8mg/L; ticarcillin, R4mg/L; mezlocillin, R4mg/
L; azlocillin, R4mg/L; cefotiam, R8mg/L; ce¢xim, R8
mg/L; ceftibutene,R32mg/L; biapenem,R4mg/L; aztreo-
nam, R8mg/L; pe£oxacin, R1mg/L; pipemidic acid, R4
mg/L; roxithromycinR1mg/L; lincomycin,R2mg/L; fos-
fomycin, R64mg/L; and fusidic acid, R2mg/L. The MIC
breakpoints for streptomycin, neomycin, spectinomycin,
pe£oxacin, pipemidic acid and lincomycin were chosen to be
similar to French standards; the MIC breakpoints for roxi-
thromycin, fosfomycin and fusidic acid correspond to Swedish
assessment criteria.The majority of the remaining breakpoints
(e.g. breakpoints for several b-lactams) are similar to the
NCCLS criteriavalid for Enterobacteriaceae.
R E S U L TS
Although there were no signi¢cant di¡erences in natural sus-
ceptibility to numerous antibiotics among the species, there
were others to which species-speci¢c susceptibilities were
detected. All Listeria species were naturally sensitive or inter-
mediate to tetracyclines, aminoglycosides, penicillins (except
for oxacillin), ¢rst- and second-generation cephalosporins
(cefaclor, cefazolin, loracarbef), cefotiam, cefoperazone, car-
bapenems, macrolides, lincosamides, glycopeptides, dalfo-
pristin/quinupristin and chloramphenicol. A natural
sensitivity of all species was also shown to rifampicin,
although the natural population of L. grayi was not clearly
ascertainable. Listeria spp. were naturally resistant or inter-
mediate tomost `modern'cephalosporins (cefetamet, ce¢xime,
ceftibutene, ceftazidime, cefdinir, cefpodoxime, cefotaxime,
ceftriaxone, cefuroxime; see below), aztreonam, pipemidic
acid, dalfopristin quinupristin and sulfamethoxazole. Signi¢-
cant di¡erences in natural susceptibility among the species
were seen with the £uoroquinolones, trimethoprim, co-tri-
moxazole, rifampicin, fosfomycin and fusidic acid. L. grayiwas
naturally resistant to trimethoprim and co-trimoxazole, least
susceptible to rifampicin and most susceptible to quinolones,
whereas L. ivanoviiwas naturally resistant to most quinolones.
L. ivanovii was naturally sensitive to fosfomycin, whereas L.
innocua and L.monocytogeneswere naturally resistant. L. ivanovii
was also themost susceptible species to fusidic acid.
An overview of the antibiotic susceptibilities of the tested
Listeria strains is presented in Figure1.The MICs of antibiotics
are presented separately for each species for which a distinctive
pattern was demonstrated (Figure1). The natural antibiotic
sensitivities and primary resistances of Listeria spp. are sum-
marized in Figure 2.
Medium dependency in susceptibility testing
For most of the tested antibiotics, there were no or minor dif-
ferences in susceptibility dependent on the medium. These
antibiotics included the aminoglycosides, most b-lactam anti-
biotics, quinolones, tetracyclines, streptogramins, chloram-
phenicol, antifolates, nitrofurantoin, fosfomycin, rifampicin
and fusidic acid. For all the species, the MICs of macrolides
were generally two dilution steps higher in CAMHB than in
H-Medium; conversely, glycopeptide MICs were two to three
dilution steps higher in H-Medium (data not shown). These
di¡erences did not a¡ect the clinical assessment of natural sus-
ceptibilities. However, there were some cephalosporins for
which there were medium-dependent di¡erences in suscept-
ibility partly a¡ecting clinical assessment. Generally, for these
antibiotics the chosen test strains showed higher susceptibil-
ities in H-Medium, but the extent of these discrepancies dif-
fered among the species. The greatest medium-dependent
di¡erences were seen with some L. welshimeri strains, which
were resistant to cefdinir (MICs 8^32mg/L) and highly resis-
tant to cefpodoxime, cefotaxime, ceftriaxone and cefuroxime
inMueller^Hinton medium (MICs>64mg/L), while being
intermediate to cefdinir and havingMICs of 4^16mg/L to the
latter cephalosporins in H-Medium (data not shown). Similar
phenomena were seen with L. seeligeri andöto a lesser
extentöwith L. grayi. Minor medium-dependent susceptibil-
ities to the mentioned cephalosporins were seen with L. inno-
cua, L. monocytogenes and L. ivanovii strains. However, because
of more clarity and the clinical signi¢cance of the latter spe-
cies, all listeriae were described as being naturally resistant to
cefdinir, cefpodoxime, cefotaxime, ceftriaxone and cefurox-
ime (see above and Figure 2).
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Figure 1 Antibiotic susceptibility of Listeria spp.
aMIC values differ signi®cantly from those obtained in CAMHB (see results).
äáð Clinical Microbiology and Infection, Volume 6 Number 10, October 2000
= 2000 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 6, 525±535
Figure 1 continued
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D IS C U S S IO N
The results of the present study show that all Listeria species
currently known show similar natural susceptibility patterns
to numerous antibiotics, but there are also several agents to
which there are species-dependent di¡erences in natural anti-
biotic susceptibility (Figure 2).This is in contrast to the widely
held opinion based upon the studies of Espaze et al [18] and
MacGowan et al [19], showing only species-dependent di¡er-
ences in susceptibility to fosfomycin.
Apart from L. grayi, listeriae possess typical natural suscept-
ibility patterns to various antimicrobial agents expected for
many Gram-positive bacteria, such as natural sensitivity to
glycopeptides, tetracyclines, trimethoprim, penicillins, carba-
penems, rifampicin, macrolides, lincosamides and chloram-
phenicol, decreased susceptibility to £uoroquinolones and
natural resistance to most cephalosporins and non-£uoroqui-
nolones. These data are in agreement with the data from the
literature [1,19^23]; however, in most studies only a few strains
of species other than L. monocytogenes or a small number of
antibiotics had been tested, and there is little information on
natural antibiotic susceptibility patterns.
Susceptibility patterns characteristic for the genus Listeria
were re£ected by the uniform natural aminoglycoside sensi-
tivity of all species and the obvious natural resistance to sulfa-
methoxazole and `modern' cephalosporins. In the literature,
the activity of aminoglycosides against listeriae is well docu-
mented [24]. However, it is not known why in the present
aMIC values differ signi®cantly from those obtained in CAMHB (see results).
The number of strains for the corresponding MIC value is cited. A number in the lowest concentration of the antibiotic represents
the maximal MIC value of this concentration (MICCmin4MICRCmin). A MIC value higher than the highest concentration tested is
cited in the subsequent higher concentration step. MIC values in shaded areas indicate the clinically intermediate area according
to the American standard (NCCLS) valid for Listeria spp. (indicated as (1) in the table) [16] or Staphylococcus aureus strains (indi-
cated as (2)) [17]. A thick black line indicates the NCCLS breakpoint between the clinically sensitive and resistant strains, if the
interpretation `intermediate' does not exist. For antibiotics to which neither Listeria nor Staphylococcus NCCLS clinical assessment
criteria exist, breakpoints for sensitivity were de®ned (indicated as (3); see Materials and Methods).
Figure 1 continued
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Figure 2 Natural antibiotic susceptibility of Listeria spp., classi®ed as sensitive, intermediate and resistant according to the stan-
dards mentioned in Figure 1.
aSee Results.bThe natural populations of Listeria grayi susceptible to rifampicin and fosfomycin were not unequivocally ascertain-
able.cSee Discussion. Note: If less than 10% of the strains belonging to a natural population were attributable to one of the clinical
categories, these strains were not taken into consideration.
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study all listeriae were highly resistant to sulfamethoxazole in
both H-Medium and CAMHB, whereas Hof et al found some
activity of sulfamethoxazole against 13 L. monocytogenes strains
using Mueller^Hinton medium for susceptibility testing
[24]. Although it cannot be excluded that probable di¡erences
in the cation and anion composition of the media have con-
tributed to the observed phenotypes, the background of the
observed discrepancies remains obscure.
Natural resistance to broad-spectrum cephalosporins asso-
ciatedwith natural sensitivity to older cephalosporins is a phe-
nomenon also found in lactobacilli and Bacillus spp. and is
associatedwith the lackof appropriate penicillin-binding pro-
teins (PBPs) in the Listeria cytoplasmic membrane [24]. Listeria
spp. possess ¢ve PBPs that are characterized by di¡erent mole-
cular masses [24]. PBP3 is considered to be the primary target
for active b-lactams in Listeria, since enzyme blockage has
lethal consequences for the bacterial cell [25]. Broad-spectrum
cephalosporins, as well as monobactams, do not bind with
high a¤nity to PBP3, whereas several penicillins (and prob-
ably some ¢rst- and second-generation-cephalosporins) do
[24].
An interesting aspect of the present study is the Listeria sus-
ceptibility pattern to co-trimoxazole. First-choice treatment
of listeriosis generally consists of ampicillin combined with
gentamicin, or of co-trimoxazole [26,27]. Whereas good
activity for the former antibiotics was con¢rmed, our data
suggest that approximately half of all listeriae except for L.
grayiwere naturally low-level resistant to co-trimoxazole (Fig-
ure1).This ¢nding is surprising, especially because co-trimox-
azoleöapart from its use in combination with an
aminopenicillinöis the second choice for the treatment of lis-
teria infections [27], and resistance to antifolates (except sulfa-
methoxazole) in `pathogenic' listeriae is very rare [20]. Thus,
our results primarily point to the lack of suitable NCCLS
breakpoints for co-trimoxazole and Listeria spp. The NCCLS
breakpoint de¢ned for staphylococci (see Figure1 [17]) sepa-
rates the natural population of all Listeria species except that of
L. grayi, leading to 39 additional r`esistant' strains. Changing
the NCCLS breakpoint for resistance from r4mg/L to r8
mg/L would correspond to 100% co-trimoxazole sensitivity
for all Listeria strains not belonging to L. ivanovii or L. grayi
(Figure1). Another point taken into consideration is the thy-
midine content of the applied media. H-Medium and
CAMHB both contain thymidine, which antagonizes the
activity of co-trimoxazole and trimethoprim [28]. However,
because all the appropriate strains were highly susceptible to
trimethoprim (Figure1), the thymidine content of the applied
media is likely to be of secondary signi¢cance for the observed
phenotype.
A new insight into natural antibiotic resistance is the
obvious resistance of L. grayi strains to all antifolates. Although
only 10 strains were tested, it seems likely that the observed
antifolate patterns are a natural phenomenon, favored by the
uniformity in susceptibility and the selected strains originat-
ing from di¡erent countries and di¡erent sources (see Materi-
als and methods). Secondary resistance to trimethoprim in L.
monocytogenes was recently attributed to a 3.7-kb plasmid
(pIP823) containing a gene (dfrD) coding for a high-level tri-
methoprim-resistant dihydrofolate reductase [29]. Because the
host range of pIP823 was shown to be broad, and conjugative
mobilization of pIP823 was obtained by self-transferable plas-
mids between di¡erent species [30], it is likely that a stable
pIP823 or a chromosomally encoded sequence containing or
resembling dfrD occurs in L. grayi strains. The unique natural
susceptibility patterns of L. grayi among Listeria spp. to tri-
methoprim and co-trimoxazole, quinolones and rifampicin
con¢rm its status as a Listeria species showing a separate line of
descent [3,4] and support the assignment of `L. murrayi'ö
whose type strainwas included in the present studyöas a sub-
species of L. grayi.
In the coming years, several studies will be needed to eluci-
date the mechanisms contributing to the observed species-
speci¢c natural antimicrobial susceptibilities among Listeria
species. It might be possible that variations in the composi-
tions of the cell walls contribute to the di¡erences in suscept-
ibility to the £uroquinolones, fusidic acid, fosfomycin and
rifampicin. It can be assumed that there are particular uptake
mechanisms for fosfomycin and fusidic acid in L. ivanovii
which are absent in other listeriae.The clinical signi¢cance of
these ¢ndings has yet to be proven.
In conclusion, the present study represents a database for
the natural susceptibilityof Listeria spp. to awide range of anti-
biotics.This database can be used for the validation of antibio-
tic susceptibility test results of Listeria spp., especially with
those antibiotics to which the species are naturally resistant. If
Listeria strains are found that are sensitive to these antibiotics,
antibiotic susceptibility testing should be repeated and identi-
¢cation results con¢rmed. It has to be elucidated whether the
present study might extend the possibilities for the e¡ective
treatment of Listeria infections.
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